Elise Stokes

Dr. Mina Bissell spearheaded research into the role of tissue architecture and the cellular microenvironment in cancer. Her research highlighted the crucial role of the tumor microenvironment in #BreastCancer biology and #CancerTreatment. Learn more: bcrf.org/blog/bcrf-investiga…

Dr. Maria Jasin's DNA repair research paved the way for other discoveries, including CRISPR gene editing. Her studies continue to explore the development of BRCA-related #BreastCancer and identifying targeted prevention strategies. Learn more: mskcc.org/news/big-break-mar…

Join us on Wednesday, April 9, 2025, for the first Oregon Drug Discovery Symposium (ODDS) at Oregon Health & Science University (OHSU). Virtual attendance is FREE with registration. Register now: ohsu.edu/knight-cancer-insti… #ODDS2025 #DrugDiscovery #Biotech @OHSUNews

Dr. Jane C. Wright pioneered research into the treatment of #BreastCancer with the drug methotrexate. Known as the “Godmother of Chemotherapy,” her work has saved millions of lives. Learn more: nationalbreastcancer.org/blo… @NBCF #WomenInHistory #CancerResearch

#BreastCancer is the second leading cause of death from cancer in American women. Preventative measures can be taken to reduce the risk of breast cancer, such as exercising regularly and lowering alcohol intake. Learn more: cancer.gov/types/breast/pati… @theNCI #CancerPreventionMonth

We are proud sponsors of the 2025 Stanford Drug Symposium (SDDS). Last year’s symposium was a pleasure to be part of, and we look forward to connecting with other members of the #DrugDiscovery community again. Learn more about #SDDS2025: med.stanford.edu/content/sm/…

Over 13,000 women in the United States are diagnosed with #CervicalCancer each year, and more than 4,000 of these women pass away. Learn more about cervical cancer prevention: nccc-online.org/understandin… @StopHPVCancer #CervicalCancerAwareness

Triple-negative breast cancer (TNBC) has different receptors from most types of #BreastCancer and a high rate of recurrence. #TNBC lacks the receptors doctors typically target when treating breast cancer and cannot be treated by targeting them. Learn more: mdanderson.org/cancerwise/tr…

Breast surgery patients may experience pain and stiffness, limiting arm and shoulder movement. Learn what exercises @AmericanCancer and the Oncology Section of @APTAtweets recommend for these side effects: cancer.org/cancer/types/brea… #PhysicalTherapyMonth #BreastCancer #CancerRehab

#PhysicalTherapy can help patients improve strength, function, and independence during and after #CancerTreatment. For instance, those treated for gynecologic cancer can use physical therapy for lymphedema, scar-tissue treatment, and more. Learn more: fredhutch.org/en/patient-car…

#OvarianCancer is usually only detected at an advanced stage. Recognizing potential symptoms and reporting them to a professional can increase the likelihood of an earlier diagnosis and successful treatment. Learn more: cancer.org/cancer/types/ovar… #OvarianCancerAwarenessMonth

. @ocrahope has invested over $122 million in ovarian and related gynecologic research. Their support has led to great progress in understanding, preventing, and treating ovarian and other gynecological cancers. Get involved: ocrahope.org/get-involved/ #OvarianCancerAwarenessMonth

@AmericanCancer Photo cred: @NOCC_National

About 1.1% of women will develop #OvarianCancer, with a 50.9% five-year survival rate. Join the @AACR in observing #OvarianCancerAwarenessMonth to raise awareness and improve prevention and treatment for this devastating disease. Get involved: aacr.org/patients-caregivers…

The @OHSUKnight's Center for Experimental Therapeutics has been selected as the first Pacific Northwest cancer center to join the Chemical Biology Consortium (CBC), which aims to tackle the challenges of #CancerTreatment. Read more: kdrv.com/news/ohsu-joins-can… @OHSUNews @theNCI

While chemotherapy can work well for #OvarianCancer at first, the cancer reoccurs in 70-90% of cases and can grow resistance. Understanding why this happens is essential to learning how we can combat #TreatmentResistance in ovarian cancer. Learn more: ovarian.org.uk/our-research/…

.@OHSUKnight researchers create the first drug to inhibit YB-1, a pro-oncogenic protein linked to cancer treatment resistance. This #DrugDiscovery exhibits anti-tumor activity, setting its game-changing potential in the fight against #TNBC. Read more: discoverybiotech.com/newsroo…

A @UPMC study found that targeting the protein follistatin improved chemotherapy response in ovarian cancer and increased survival rates in the mouse model. How will their findings impact future human clinical trials? Learn more: inside.upmc.com/chemotherapy… @AsherGJones #Oncology

Drs. Sanjay Malhotra, Becca Spain, and Dan Streblow received OCTRI's BIP awards. This BIP track supports #DrugDiscovery, including validation of drug targets and development of small molecules, antibodies, vaccines or biologics. Read more: now.ohsu.edu/member/post/thr… #BreastCancer

Triple-negative breast cancer accounts for 15-20% of all breast cancers with a worse prognosis. Learn about the groundbreaking discovery made by Dr. Sanjay Malhotra and his team of researchers in our promising new cancer treatment: discoverybiotech.com/newsroo… #drugdiscovery